Serotonin reuptake inhibitors augmentation with cariprazine in patients with treatment-resistant obsessive-compulsive disorder: a retrospective observational study

被引：3
|
作者：
Martiadis, Vassilis [1 ]
Pessina, Enrico [2 ]
Martini, Azzurra [2 ]
Raffone, Fabiola [1 ]
Cattaneo, Carlo I. [3 ]
De Berardis, Domenico [4 ]
Pampaloni, Ilenia [5 ]
机构：
[1] ASL Napoli 1 Ctr, Dept Mental Hlth, Naples, Italy
[2] ASL CN2, Dept Mental Hlth, Bra, Italy
[3] ASL 12, Dept Mental Hlth, Biella, Italy
[4] ASL 4 Teramo, Dept Mental Hlth, Teramo, Italy
[5] South West London & St Georges Mental Hlth NHS Tru, Natl OCD BDD Serv, London, England
来源：
CNS SPECTRUMS | 2024年
关键词：
OCD; augmentation strategies; cariprazine; antipsychotic augmentation; refractory OCD; ANTIPSYCHOTIC AUGMENTATION; DOUBLE-BLIND;
D O I：
10.1017/S1092852924000348
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：296 / 299
页数：4
相关论文
共 50 条
  • [21] Treatment strategies for serotonin reuptake inhibitor-resistant obsessive-compulsive disorder: A network meta-analysis of randomised controlled trials
    Suhas, Satish
    Malo, Palash Kumar
    Kumar, Vijay
    Issac, Thomas Gregor
    Chithra, Nellai K.
    Bhaskarapillai, Binukumar
    Reddy, Y. C. Janardhan
    Rao, Naren P.
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2023, 24 (02) : 162 - 177
  • [22] Ondansetron Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder A Preliminary, Single-Blind, Prospective Study
    Pallanti, Stefano
    Bernardi, Silvia
    Antonini, Sarah
    Singh, Nikhilesh
    Hollander, Eric
    CNS DRUGS, 2009, 23 (12) : 1047 - 1055
  • [23] Cariprazine Augmentation in Treatment-Resistant Bipolar Depression: Data from a Retrospective Observational Study
    Teobaldi, Elena
    Pessina, Enrico
    Martini, Azzurra
    Cattaneo, Carlo Ignazio
    De Berardis, Domenico
    Martiadis, Vassilis
    Maina, Giuseppe
    Rosso, Gianluca
    CURRENT NEUROPHARMACOLOGY, 2024, 22 (10) : 1742 - 1748
  • [24] Treatment-Resistant Obsessive-Compulsive Disorder: Neurocognitive and Clinical Correlates
    Dinn, Wayne M.
    Aycicegi-Dinn, Ayse
    Goral, Fatma
    Darkal, Ola
    Yildirim, Ejder Akgun
    Hacioglu, Munevver
    FUTURE ACADEMY MULTIDISCIPLINARY CONFERENCE ICEEPSY & CPSYC & ICPSIRS & BE-CI, 2016, 217 : 1189 - 1198
  • [25] Treatment-Resistant Obsessive-Compulsive Disorder: Clinical and Personality Correlates
    Dinn, Wayne M.
    Aycicegi-Dinn, Ayse
    Goral, Fatma
    Yildirim, Ejder Akgun
    Hacioglu, Munevver
    5TH WORLD CONFERENCE ON PSYCHOLOGY, COUNSELING AND GUIDANCE, WCPCG-2014, 2014, 159 : 239 - 242
  • [26] Lumateperone monotherapy for treatment-resistant obsessive-compulsive disorder in an adolescent
    Naguy, Ahmed
    Pridmore, Saxby
    Abuzeid, Mohamed Y.
    Elsori, Dalal
    Alamiri, Bibi
    CNS SPECTRUMS, 2024, 29 (01) : 4 - 5
  • [27] Augmenting Selective Serotonin Reuptake Inhibitors With Clomipramine in Obsessive-Compulsive Disorder: Benefits and Risks
    Andrade, Chittaranjan
    JOURNAL OF CLINICAL PSYCHIATRY, 2013, 74 (12) : E1128 - E1133
  • [28] Therapies for obsessive-compulsive disorder: Current state of the art and perspectives for approaching treatment-resistant patients
    Swierkosz-Lenart, Kevin
    Dos Santos, Joao Flores Alves
    Elowe, Julien
    Clair, Anne-Helene
    Bally, Julien F.
    Riquier, Francoise
    Bloch, Jocelyne
    Draganski, Bogdan
    Clerc, Marie-Therese
    Moyano, Beatriz Pozuelo
    von Gunten, Armin
    Mallet, Luc
    FRONTIERS IN PSYCHIATRY, 2023, 14
  • [29] A comparative, single-blind, randomized study on quetiapine and aripiperazole augmentation in treatment of selective serotonin reuptake inhibitor refractory obsessive-compulsive disorder
    Talaei, Ali
    Hosseini, Farhad Farid
    Aghili, Zahra
    Akhondzadeh, Shahin
    Asadpour, Elham
    Mehramiz, Neema John
    Forouzanfar, Fatemeh
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2020, 98 (04) : 236 - 242
  • [30] Amisulpiride augmentation in treatment resistant obsessive-compulsive disorder:: an open trial
    Metin, Ö
    Yazici, K
    Tot, S
    Yazici, AE
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2003, 18 (06) : 463 - 467
12345